Headquartered in San Ramon, CA Fiscal year ends October NASDAQ: COO coopercos.com
CooperCompanies (Nasdaq: COO) is a global medical device company operating through two business units. CooperVision is a major contact lens manufacturer offering toric, multifocal, sphere, and other lens products sold across the Americas, EMEA, and Asia Pacific regions. CooperSurgical is a fertility and women's healthcare company with two main product categories: office and surgical products, and fertility services and products. The company sells products in over 130 countries, employs more than 15,000 people, and serves over fifty million lives annually. CooperCompanies recently completed a comprehensive strategic review that resulted in the retention of CooperSurgical and the implementation of operational initiatives including expanded commercial execution at CooperVision, cost optimization programs, revised inventory and logistics approaches, and accelerated innovation through new product introductions and the opening of a new global R&D innovation hub. Updated
Markets are taking a beating as crude oil surges past $100 and Treasury yields hit multi-year highs, setting up a make-or-break inflation report that could seal the Fed's next move. Wall Street…
Pre-Market Stock Futures: The futures are trading higher as traders and investors came in yet again to buy the dip on Tuesday after the market opened, then plunged over 1,100 points before…
Pre-Market Stock Futures: The stock futures are trading lower on Thursday, following another incredible day for the Dow Jones Industrials, while the rotation out of the NASDAQ and into technology is still…
Wednesday's top analyst upgrades and downgrades included Abbott Laboratories, Boston Scientific, ChargePoint, Coinbase Global, Dollar General, Equitrans Midstream, Ford, Hasbro, Johnson & Johnson, Kenvue and Medtronic.
Tech megacap stocks led the burst of enthusiasm for equities on Friday. Can they produce another win on Monday?
Tuesday's top analyst upgrades and downgrades included Home Depot, Intuitive Surgical, Mastercard, McDonald's, Monster Beverage, Penn National Gaming, Shoals Technologies, Starbucks, Take-Two Interactive Software, Teva Pharmaceutical Industries and Workday.
Friday afternoon's top analyst upgrades and downgrades included Aramark, Baxter International, Ingersoll Rand and Walgreens Boots Alliance.
Thursday's top analyst upgrades, downgrades and initiations included Abbott Laboratories, Alexion Pharmaceuticals, Avis Budget, DexCom, Johnson & Johnson, Marvell Technology, Moderna, Snap, Splunk and Zoom Video Communications.
Thursday was a positive day for the broad U.S. markets. Each of the major exchanges started out the day on a negative note, but as the session went on markets moved higher.…
Friday was a down day for the broad U.S. markets. Each of the major averages fell more than 2% to end the session. Crude oil posted a massive gain on the day.
Monday was a mixed day for the broad U.S. markets. At first all three major indices started out positive, but over the course of the day they fluctuated between positive and negative,…
Monday’s top analyst upgrades, downgrades and initiations include Advanced Micro Devices, CVS Health, ConocoPhillips, EOG Resources, Seattle Genetics and WebMD.
The top analyst upgrades, downgrades and initiations seen on Wednesday morning include Clovis Oncology, Garmin, Lowe's, NetApp, On Deck, Pioneer Natural and RSP Permian.
Wednesday's top analyst upgrades, downgrades and initiations include Amazon.com, Best Buy, Google, IBM, Marathon Petroleum, Nike and WisdomTree Investments.
As we head into the second quarter and a new earnings season, it is very possible that the insider selling that was so big last month will start to taper off.
CooperCompanies (Nasdaq: COO) is a global medical device company operating through two business units. CooperVision is a major contact lens manufacturer offering toric, multifocal, sphere, and other lens products sold across the Americas, EMEA, and Asia Pacific regions.
24/7 Wall St.'s 12-month price target for COO is $68.50, rated Buy. The Wall Street consensus target is $65.80. COO price prediction →
